682
U. Bhakta et al. / Tetrahedron 70 (2014) 678e683
hexanes, 0.5 mL/min,
l
¼254 nm, column temperature¼25 ꢁC),
7.0 Hz, 1H), 5.29e5.24 (m, 2H), 4.65e4.61 (m, 1H), 2.57e2.54 (m,
2H), 2.2 (br s, 1H); 13C NMR (125 MHz, CDCl3)
1C), 133.6 (d, J¼8.5 Hz, 2C), 132.9, 119.1, 118.6 (d, J¼3.4 Hz, 2C), 115.5
(d, J¼22 Hz, 2C), 89.1, 84.1, 62.0, 42.2; EI HRMS calcd for C12H11FONa
213.0686, found 213.0690.
Tmajor¼19.9 min, Tminor¼10.4 min; ½a D22
ꢄ
58.7 (c 1.15, CHCl3); Rf¼0.1
d
163.5 (d, J¼250 Hz,
(hexanes/EtOAc 10:1), IR (film cast, CHCl3): 3338 (broad, m), 3077
(w), 3006 (w), 2979 (w), 2930 (s), 2854 (s), 2229 (w), 1642 (m),
1448 (m), 1338 (w), 1035 (s), 861 (s) cmꢀ1 1H NMR (500 MHz,
;
CDCl3)
d
5.87 (ddt, J¼17.0, 10, 7.5 Hz, 1H), 5.18e5.13 (m, 2H), 4.40
(ddd, J¼11.5, 6, 2 Hz, 1H), 2.46e2.41 (m, 2H), 2.40e2.34 (m, 1H),
1.97e1.94 (m, 1H), 1.80e1.73 (m, 2H), 1.71e1.64 (m, 2H), 1.51e1.47
(m, 1H), 1.44e1.37 (m, 2H), 1.31e1.24 (m, 3H); 13C NMR (125 MHz,
4.3. Characterization of enantioselective crotylboration
products
CDCl3)
d
133.4, 118.5, 90, 80.5, 61.8, 42.6, 32.6, 28.9, 25.8, 24.8; EI
4.3.1. Methyl-7-phenyloct-5-en-1-yn-3-ol (4a). A 91% ee was de-
termined by HPLC analysis (Chiralcel OD column, 40% i-PrOH in
HRMS calcd for C15H18ONa 201.1257, found 201.1244.
hexanes, 0.5 mL/min,
l
¼254 nm, column temperature¼25 ꢁC),
4.2.8. 1-Cyclopropylhex-5-en-1-yn-3-ol (3h). A 81% ee was de-
termined by HPLC analysis (Chiralcel OD column, 10% i-PrOH in
Tmajor¼7.63 min, Tminor¼11.26 min; ½a D22
ꢄ
24.2 (c 1.3, CHCl3); IR (film
cast, CHCl3): 3400 (broad, m), 3064 (s), 2965 (s), 2928 (m), 2861 (s),
2229 (m), 1640 (s), 1603 (s), 1496 (s), 1454 (s), 1440 (m), 1429 (m),
hexanes, 0.5 mL/min,
l
¼254 nm, column temperature¼25 ꢁC),
Tmajor¼24.4 min, Tminor¼13.4 min; ½a D22
ꢄ
71.1 (c 1.05, CHCl3); Rf¼0.1
1419 (m) cmꢀ1 1H NMR (400 MHz, CDCl3)
; d 7.28e7.34 (m, 2H),
(hexanes/EtOAc 10:1); IR (film cast, CHCl3): 3351 (broad, m), 3078
7.24e7.2 (m, 3H), 5.84e5.74 (m, 1H), 5.18e5.12 (m, 2H), 4.22e4.17
(m, 1H), 2.85 (t, 7.6 Hz, 2H), 2.55 (dt, J¼7.2, 1.6 Hz, 2H), 2.45e2.37
(m, 1H), 1.92 (d, J¼5.2 Hz, 1H), 1.1 (d, J¼6.8 Hz, 3H); 13C NMR
(m), 3011 (m), 2980 (w), 2914 (m), 2866 (w), 2240 (m), 1641 (m),
1429 (m), 1358 (m), 1052 (s), 1030 (s), 813 (m) cmꢀ1 1H NMR
;
(500 MHz, CDCl3)
d
5.88e5.8 (m, 1H), 5.16e5.11 (m, 2H), 4.36e4.32
(125 MHz, CDCl3) d 140.5, 139.5, 128.4, 128.3, 126.3, 116.5, 85.7, 80.3,
(m, 1H), 2.41e2.38 (m, 2H), 2.04e2.02 (m, 1H), 1.25e1.2 (m, 1H),
66.3, 44.5, 35.0, 20.9, 15.2; EI HRMS calcd for C15H18ONa 237.1250,
found 237.1245.
0.72e0.76 (m, 2H), 0.66e0.63 (m, 2H); 13C NMR (125 MHz, CDCl3)
d
133.3, 118.5, 88.9, 75.7, 61.7, 42.5, 8.2, ꢀ0.6; EI HRMS calcd for
C9H12ONa 159.0785, found 159.0777.
4.3.2. Methyl-8-phenylnon-1-en-5-yn-4-ol (4b). A 80% ee was de-
termined by HPLC analysis (Chiralcel OD column, 10% i-PrOH in
4.2.9. (3S)-1-Phenylhex-5-en-1-yn-3-ol (3i). A 69% ee was de-
termined by HPLC analysis (Chiralcel OD column, 50% i-PrOH in
hexanes, 0.5 mL/min,
l
¼254 nm, column temperature¼25 ꢁC),
Tmajor¼11.3 min, Tminor¼12.7 min; ½a D22
ꢄ
15.3 (c 1.8, CHCl3); IR (film
hexanes, 0.5 mL/min,
l
¼210 nm, column temperature¼25 ꢁC),
cast, CHCl3): 3371 (broad, m), 3064 (s), 2964 (s), 2932 (m), 2862 (s),
2238 (m), 1640 (s), 1602 (s), 1496 (s), 1454 (s), 1430 (m), 1419 (m)
Tmajor¼7.3 min, Tminor¼9.3 min; ½a D22
ꢄ
26.0 (c 0.36, CHCl3). Spectral
and analytical properties of the product were in accordance with
cmꢀ1 1H NMR (500 MHz, CDCl3)
; d 7.35e7.19 (m, 5H), 5.91 (ddd,
the literature.6h
J¼17.9, 10.4, 7.5 Hz, 1H), 5.24e5.15 (m, 2H), 4.26 (m, 1H), 2.76 (t,
J¼7.5 Hz, 2H), 2.52e2.44 (m,1H), 2.28 (td, J¼7.0, 2.0 Hz, 2H),1.91 (br
s, 1H), 1.87 (m, 2H), 1.18 (d, J¼6.8 Hz, 3H); 13C NMR (125 MHz,
4.2.10. 1-(4-Methylphenyl)hex-5-en-1-yn-3-ol (3j). A 58% ee was
determined by HPLC analysis (Chiralcel OD column, 50% i-PrOH in
CDCl3) d 141.6, 139.6, 128.5, 128.3, 125.9, 116.5, 86.0, 80.1, 66.4, 44.7,
hexanes, 0.5 mL/min,
l
¼254 nm, column temperature¼25 ꢁC),
34.8, 30.3, 18.2, 15.3; EI HRMS calcd for C16H20ONa 251.1406, found
251.1402.
Tmajor¼6.9 min, Tminor¼8.3 min; ½a D22
22.6 (c 1.2, CHCl3); Rf¼0.1
ꢄ
(hexanes/EtOAc 10:1); IR (film cast, CHCl3): 3375 (broad, m), 3078
(s), 3029 (s), 2980 (s), 2921 (m), 2860 (s), 2202 (m), 1666 (m), 1643
4.3.3. Methyl-1-trimethylsilylhex-1-en-5-yn-4-ol (4c). A 81% ee was
(m), 1606 (m), 1510 (s), 1440 (m), 1038 (s), 817 (s) cmꢀ1
;
1H NMR
determined by Mosher ester analysis; ½a D22
ꢀ0.38 (c 4.1, CHCl3);
ꢄ
(500 MHz, CDCl3)
7.0 Hz, 1H), 5.25e5.19 (m, 2H), 4.64 (t, J¼6.0 Hz, 1H), 2.58e2.55 (m,
2H), 2.3 (s, 3H), 2.0 (br s, 1H); 13C NMR (125 MHz, CDCl3)
138.5,
d
7.32 (m, 2H), 7.11 (m, 2H), 5.96 (ddt, J¼17.0, 10.5,
Rf¼0.1 (hexanes/EtOAc 10:1); IR (film cast, CHCl3): 3367 (broad, m),
3080 (w), 2963 (w), 2933 (s), 2173 (w), 1641 (m), 1456 (m), 1251 (s),
d
1030 (s), cmꢀ1; 1H NMR (500 MHz, CDCl3)
d
¼5.83 (ddd, J¼17.1, 10.5,
133.1, 131.6, 129.0, 119.4, 118.9, 88.7, 85.3, 62.1, 42.3, 21.4; EI HRMS
calcd for C13H14ONa 209.0937, found 209.0939.
7.7 Hz, 1H), 5.21e5.15 (m, 2H), 4.20 (t, J¼5.5 Hz, 1H), 2.49e2.44 (m,
1H), 1.90 (d, J¼6 Hz, 1H), 1.15 (d, J¼6.8 Hz, 3H), 0.19 (s, 9H); 13C NMR
(125 MHz, CDCl3)
HRMS calcd for C10H17ONa 204.3227, found 204.3218.
d
139.2, 116.7, 105.0, 90.5, 66.6, 44.4,15.3, ꢀ0.1; EI
4.2.11. 1-(4-Methoxyphenyl)hex-5-en-1-yn-3-ol (3k). A 50% ee was
determined by HPLC analysis (Chiralcel OD column, 50% i-PrOH in
hexanes, 0.5 mL/min,
l
¼254 nm, column temperature¼25 ꢁC),
4.3.4. Methyl-1-cyclohexylhex-5-en-1-yn-3-ol (4d). A 84% ee was
determined by HPLC analysis (Chiralcel OD column, 1.5% i-PrOH in
Tmajor¼10.9 min, Tminor¼7.4 min; ½a D22
16.1 (c 1.4, CHCl3); Rf¼0.1
ꢄ
(hexanes/EtOAc 10:1); IR (film cast, CHCl3): 3384 (broad, m), 3075
hexanes, 0.5 mL/min,
l
¼254 nm, column temperature¼25 ꢁC),
(m), 3006 (m), 2935 (m), 2913 (m), 2837 (m), 2228 (m), 1642 (m),
Tmajor¼29.9 min, Tminor¼26.2 min; ½a D22
49.3 (c 1.2, CHCl3); Rf¼0.1
ꢄ
1606 (s), 1463 (m), 1441 (m), 1031 (s), 1030 (s), 831 (m) cmꢀ1
;
1H
(hexanes/EtOAc 10:1); IR (film cast, CHCl3): 3366 (broad, m), 3078
NMR (500 MHz, CDCl3)
d
7.37 (m, 2H), 6.83 (d, 2H), 5.96 (ddt, J¼17.2,
(w), 2932 (w), 2854 (s), 2232 (w), 1640 (m), 1449 (m), 1348 (w), 1024
10.0, 7.2 Hz, 1H), 5.26e5.20 (m, 2H), 4.65e4.62 (m, 1H), 3.80 (s, 3H),
(s), cmꢀ1; 1H NMR (500 MHz, CDCl3)
d
5.83 (ddd, J¼17.4, 10.2, 7.5 Hz,
2.58e2.55 (m, 2H), 2.13 (br s, 1H); 13C NMR (100 MHz, CDCl3)
1H), 5.19e5.11 (m, 2H), 4.22 (t, J¼4.4 Hz, 1H), 2.48e2.38 (m, 2H),1.90
(d, J¼4.8 Hz, 1H), 1.83e1.75 (m, 2H), 1.74e1.66 (m, 2H), 1.55e1.40 (m,
3H), 1.36e1.27 (m, 3H), 1.13 (d, J¼7.0 Hz, 3H); 13C NMR (125 MHz,
d
159.3, 132.8, 118.5, 114.2, 113.6, 113.5, 87.6, 84.7, 61.7, 54.9, 41.9; EI
HRMS calcd for C13H14O2Na 225.0886, found 225.0885.
CDCl3) d 139.6, 116.3, 90.6, 79.4, 66.4, 44.7, 32.6, 28.9, 25.8, 24.7, 15.2;
4.2.12. 1-(4-Fluorophenyl)hex-5-en-1-yn-3-ol (3l). A 55% ee was
determined by HPLC analysis (Chiralcel OD column, 50% i-PrOH in
EI HRMS calcd for C13H20ONa 215.1406, found 215.1400.
hexanes, 0.5 mL/min,
l
¼254 nm, column temperature¼25 ꢁC),
4.3.5. Methyl-1-cyclopropylhex-5-en-1-yn-3-ol (4e). A 84% ee was
determined by HPLC analysis (Chiralcel OD column, 1.5% i-PrOH in
Tmajor¼9.3 min, Tminor¼10.9 min; ½a D22
15.6 (c 1.4, CHCl3), Rf¼0.1
ꢄ
(hexanes/EtOAc 10:1); IR (film cast, CHCl3): 3363 (broad, m), 3078
(s), 2980 (s), 2921 (m), 2860 (s), 2232 (m), 1642 (s), 1602 (s), 1507
(s), 1232 (s), 1440 (m), 1031 (m), 835 (s) cmꢀ1; 1H NMR (500 MHz,
hexanes, 0.5 mL/min,
l
¼254 nm, column temperature¼25 ꢁC),
Tmajor¼16.5 min, Tminor¼18.4 min; ½a D22
56.3 (c 1.0, CHCl3); Rf¼0.1
ꢄ
(hexanes/EtOAc 10:1); IR (film cast, CHCl3): 3318 (broad, m), 3081
CDCl3)
d
7.45e7.41 (m, 2H), 7.05e7.0 (m, 2H), 5.98 (ddt, J¼17.0, 10.5,
(m), 3011 (m), 2970 (w), 2931 (m), 2248 (m), 1601 (m), 1540 (s),